Key result
Local delivery of miR-146b-5p antagomir improves LVEF by ~12% four weeks post-MI in pigs.
Why the study?
The function of miR-146b-5p in the cardiac inflammatory cascade and its clinical implication in fibrotic remodeling following myocardial infarction remain largely unknown.
Does local delivery of a miR-146b-5p antagomir improve cardiac remodeling and function in animal models of myocardial infarction?
Does local delivery of a miR-146b-5p antagomir improve cardiac remodeling and function in animal models of myocardial infarction?
Absolute Event Rate: 48.89% vs 37.26%
p-value: p=0.039
Local inhibition of miR-146b-5p represents a potential novel therapeutic approach to treat cardiac fibrotic remodeling and dysfunction following myocardial infarction.
Supports miR-146b-5p inhibition as potential post-MI therapy in large animals; leaves open translation to human trials.
Fibrotic remodeling is an adverse consequence of immune response-driven phenotypic modulation of cardiac cells following myocardial infarction (MI). MicroRNA-146b (miR-146b) is an active regulator of immunomodulation, but its function in the cardiac inflammatory cascade and its clinical implication in fibrotic remodeling following MI remain largely unknown. Herein, miR-146b-5p was found to be upregulated in the infarcted myocardium of mice and the serum of myocardial ischemia patients. Gain- and loss-of-function experiments demonstrated that miR-146b-5p was a hypoxia-induced regulator that governed the pro-fibrotic phenotype transition of cardiac cells. Overexpression of miR-146b-5p activated fibroblast proliferation, migration, and fibroblast-to-myofibroblast transition, impaired endothelial cell function and stress survival, and disturbed macrophage paracrine signaling. Interestingly, the opposite effects were observed when miR-146b-5p expression was inhibited. Luciferase assays and rescue studies demonstrated that the miR-146b-5p target genes mediating the above phenotypic modulations included interleukin 1 receptor associated kinase 1 (IRAK1) and carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Local delivery of a miR-146b-5p antagomir significantly reduced fibrosis and cell death, and upregulated capillary and reparative macrophages in the infarcted myocardium to restore cardiac remodeling and function in both mouse and porcine MI models. Local inhibition of miR-146b-5p may represent a novel therapeutic approach to treat cardiac fibrotic remodeling and dysfunction following MI.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2020) studied Myocardial infarction (n=28). miR-146b-5p antagomir vs. Antagomir negative control was evaluated on Left ventricular ejection fraction (LVEF) at 4 weeks (p=0.039). Local delivery of a miR-146b-5p antagomir significantly improved left ventricular ejection fraction to 48.89% compared to 37.26% in control pigs 4 weeks after myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: